Medical marijuana is legal in 20 states, and selecting an appropriate
delivery method involves weighing factors such as ease of use,
effectiveness and accuracy in dosing. According to Ron Leyland,
President and CEO of Puget Technologies (OTCBB: PUGE), more research is
needed because many delivery systems currently available are not
appropriate for some patients.
Puget Technologies’ subsidiary, Cannabis Biotech, is investigating
delivery systems that offer several benefits. The systems will not
trigger respiratory ailments since many medical marijuana patients
already have debilitating illnesses. The products will feature
portability and ease of use, important to patients who must be able to
carry the medication around or out of the home. Beneficial effects will
set in rapidly and predictably, ensuring medical effectiveness.
As previously announced, Cannabis Biotech’s medical marijuana product
line will begin with a metered-dose transmucosal delivery system, a
cannabis infused beverage line and transdermal patches.
Learn more about Cannabis Biotech at http://www.cannabisbiotech.com.
About Puget Technologies (PUGE)
Puget Technologies is a publicly traded company on the OTCBB Market
stock exchange under the ticker symbol PUGE. Headquartered in Ft.
Lauderdale, Florida, Puget Technologies acquires, develops and sells
leading edge consumer oriented products ready for rapid
commercialization. Product lines under development include several
medical marijuana products through its subsidiary, Cannabis Biotech.
Puget’s strategy is to become a recognized market leader in its product
categories. Much of its resources are dedicated to research and
development to provide consumers with quality options while meeting the
expectations of its investors.
Safe Harbor Statement under the Private Securities Litigation
Reform Act of 1995: This news release contains forward-looking
information within the meaning of Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange act of
1934, as amended, including statements that include the words
"believes," "expects," "anticipates," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the company to differ materially from
those expressed or implied by such forward looking statements. In
addition, description of anyone's past success, either financial or
strategic, is no guarantee of future success. This news release only
speaks as of the date of its distribution.
Copyright Business Wire 2013